Cingulate Inc. rose 25.9% on Tuesday, November 17, 2026, on 1,626,800 shares, 9.7 times its average daily volume. No headline about CING came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Cingulate Inc. (CING:NASDAQ) closed at $4.51 on November 20, 2026, down 14.26% on the day. The stock trades 62.1% below its 52-week high of $11.89 and 42.7% above its 52-week low of $3.16. Over the past year, it gained 27.8%. Cingulate Inc. is part of the Health Care sector.
In 252 trading sessions since November 20, 2025, CING closed higher on 129 days (51%). Its best day was November 17, 2026 (+25.87%) and its worst was March 18, 2026 (-31.05%). The stock moved 10% or more in a single session 15 times. It opened at least 5% above the previous day's high 1 time.
Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.
Find more stocks like CING with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.